SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-16-005079
Filing Date
2016-07-05
Accepted
2016-07-05 16:35:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13D sc13da410109002_07052016.htm SC 13D/A 96268
  Complete submission text file 0000921895-16-005079.txt   97799
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Subject) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82467 | Film No.: 161750980
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1275 YORK AVE. NEW YORK NY 10065
Business Address 1275 YORK AVE. NEW YORK NY 10065 212-639-2000
Memorial Sloan-Kettering Cancer Center (Filed by) CIK: 0001566787 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NY
Type: SC 13D/A